Half-Year 2022 Financial and Clinical Trials Update

Exchange rate impact on sales growth Negative impact driven by the EUR, JPY and "other Europe", partially offset by USD Roche CER sales growth HY 2022 VS. HY 2021 +5.4% +0.0p -0.8p +0.1p +1.8p -0.6p -1.0p +0.3p +5.2% CHF sales growth HY 2022 VS. HY 2021 CER EUR APAC USD LATAM JPY Other Other CHF Europe CER = Constant Exchange Rates (avg full year 2021) 68

View entire presentation